Clinical Trials Logo

Healthy Male Volunteer clinical trials

View clinical trials related to Healthy Male Volunteer.

Filter by:
  • None
  • Page 1

NCT ID: NCT02233218 Completed - Clinical trials for Healthy Male Volunteer

The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

Start date: July 2014
Phase: Phase 1
Study type: Interventional

To investigate the pharmacokinetic Drug-drug interaction

NCT ID: NCT01776047 Completed - Clinical trials for Healthy Male Volunteer

A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

Start date: July 2012
Phase: Phase 1
Study type: Interventional

Study Design : randomized, open label, single-dose, 2-way cross-over design Phase : Phase I

NCT ID: NCT01442532 Completed - Clinical trials for Healthy Male Volunteer

A Study of the Safety and Pharmacokinetics of JNJ-38518168 in Japanese and Caucasian Male Participants and the Effect of JNJ-38518168 on the Blood Levels of Midazolam

Start date: September 2011
Phase: Phase 1
Study type: Interventional

The purpose of Part 1 of this study is to evaluate the safety, tolerability, and pharmacokinetics ("PK", how the drug is absorbed in the body, distributed within the body, and how it is removed from the body over time) of JNJ-38518168 in comparison with placebo following single dose and 14 days of consecutive dosing in healthy Japanese and Caucasian adult male participants. Part 2 of this study will evaluate the effect of JNJ-38518168 on the pharmacokinetics of midazolam in healthy participants.

NCT ID: NCT01133431 Completed - Clinical trials for Healthy Male Volunteer

The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea

CKD-501 DDI
Start date: May 2010
Phase: Phase 1
Study type: Interventional

To assess the pharmacokinetic Interaction between CKD-501 and sulfonylurea (Glimepiride) in healthy male subjects.

NCT ID: NCT00859352 Completed - Clinical trials for Healthy Male Volunteer

AZD1981 Midazolam CYP4503A Induction Study

Start date: March 2009
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to investigate if the exposure of midazolam is clinically significantly changed by 14 days of exposure to AZD1981 through possible enzyme induction of CYP3A.